Selective dehydrogenation of resibufogenin and cinobufagin at 3-OH by Pseudomonas aeruginosa

Enzyme and Microbial Technology

Volumn 33, Issue 1, 2003, Pages 29-32

  Zhan, Jixun ^a,b   Liu, Wenhui ^a   Guo, Hongzhu ^a   Zhang, Yuanxing ^b   Guo, Dean ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cinobufagin; Pseudomonas aeruginosa; Resibufofenin; Selective dehydrogenation

Indexed keywords

BACTERIA; DEHYDROGENATION; METABOLITES;

BIOTRANSFORMATIONS;

ENZYME KINETICS;

3 KETOCINOBUFAGIN; 3 KETODEACETYLCINOBUFAGIN; 3 KETORESIBUFOGENIN; BUFOGENIN; CINOBUFAGIN; DEACETYLCINOBUFAGIN; KETONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG TRANSFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGENATION; INTESTINE FLORA; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PSEUDOMONAS AERUGINOSA; THIN LAYER CHROMATOGRAPHY;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0037735190     PISSN: 01410229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0141-0229(03)00068-1     Document Type: Article

References (16)

1. Chen Y., Xiang J., Gu W., Xu M. Chemical constituents of Bufo siccus. China J. Chin. Materia. Medica. 23:1998;620-621.
2. Krenn L., Kopp B. Bufadienolides from animal and plant sources. Phytochemistry. 48:1998;1-29.
3. Pamnani M.B., Chen S., Yuan C.M., Haddy F.J. Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats. Hypertension. 23(Suppl. 1):1994;106-109.
4. Yuan C., Manunta P., Chen S., Hamlyn J.M., Haddy F.J., Pamnani M.B. Role of ouabain-like factors in hypertension: effects of ouabain and certain endogenous ouabain-like factors in hypertension. J. Cardiovasc. Pharmacol. 22:1993;S10-S12.
5. Xie J.T., Dey L., Wu J.A., Lowell T.K., Yuan C.S. Cardiac toxicity of resibufogenin: electrophysiological evidence. Acta Pharmacol. Sin. 22:2001;289-297.
6. Nogawa T., Kamano Y., Yamashita A., Pettit G.R. Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch'an Su. J. Nat. Prod. 64:2001;1148-1152.
7. Terness P., Navolan D., Dufter C., Kopp B., Opelz G. The T-cell suppressive effect of bufadienolides: structural requirements for their immunoregulatory activity. Internat Immunopharmacol. 1:2001;119-134.
8. Zhang L., Nakaya K., Yoshida T., Kuroiwa Y. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res. 52:1992;4634-4641.
9. Kamano Y., Kotake A., Hashima H., Inoue M., Morita H., Takeya K.et al. Structure-cytotoxic activity relationship for the toad poison bufadienolides. Bioorg. Med. Chem. 6:1998;1103-1115.
10. Abourashed E.A., Clark A.M., Hufford C.D. Microbial models of mammalian metabolism of xenobiotics: an updated review. Curr. Med. Chem. 6:1999;359-374.
11. Yang X.W., Xing Z.T., Cui J.R., Fan Y.L., Zhao R., Li X.G. Studies on the metabolism of cinobufagin and cinobufotalin by human intestinal bacteria. J. Peking Univ. (Health Sci.). 33:2001;199-204.
12. Peterkofsky A. The mechanism of action of histidase: amino-enzyme formation and partial reactions. J. Biol. Chem. 237:1962;787.
13. Misono H., Shinagawa Y., Nagata S., Nagasaki S. Occurrence of D-threonine dehydrogenase in Pseudomonas cruciviae. Agric Biol. Chem. 51:1987;1467-1469.
14. Steele M.I., Lorenz D., Hatter K., Park A., Sokatch J.R. Characterization of the mms AB operon of Pseudomonas aeruginosa PAO encoding methylmalonate semialdehyde dehydrogenase and 3-hydroxyisobutyrate dehydrogenase. J. Biol. Chem. 267:1992;13585-13592.
15. Hao JY, Cai WC. Microbial enzymes. Beijing: Scientific Press; 1986. p. 200-3.
16. Zhang L.S., Yoshida T., Aoki K., Kuroiwa Y. Metabolism of cinobufagin in rat liver microsomes. Identification of epimerized and deacetylated metabolites by liquid chromatography/mass spectrometry. Drug Metab. Dispos. 19:1991;917-919.